candesartan cilexetil has been researched along with Cancer of Prostate in 2 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashiyama, A | 1 |
| Yokoyama, T | 1 |
| Omoto, Y | 1 |
| Habe, K | 1 |
| Yamanaka, K | 1 |
| Mizutani, H | 1 |
| Shirotake, S | 1 |
| Miyajima, A | 1 |
| Kosaka, T | 1 |
| Tanaka, N | 1 |
| Kikuchi, E | 1 |
| Mikami, S | 1 |
| Okada, Y | 1 |
| Oya, M | 1 |
2 other studies available for candesartan cilexetil and Cancer of Prostate
| Article | Year |
|---|---|
Flutamide-induced photoleukomelanoderma.
Topics: Administration, Cutaneous; Aged; Androgen Antagonists; Benzimidazoles; Biopsy; Biphenyl Compounds; B | 2016 |
Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl | 2012 |